Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 623732, 7 pages
http://dx.doi.org/10.1155/2015/623732
Clinical Study

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

1Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung District, Kaohsiung City 833, Taiwan
2Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung District, Kaohsiung City 833, Taiwan
3Division of Internal Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung District, Kaohsiung City 833, Taiwan

Received 4 December 2014; Accepted 10 January 2015

Academic Editor: Khean-Lee Goh

Copyright © 2015 Wei-Chen Tai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Wei-Chen Tai, Chih-Ming Liang, Chen-Hsiang Lee, et al., “Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication,” BioMed Research International, vol. 2015, Article ID 623732, 7 pages, 2015. https://doi.org/10.1155/2015/623732.